LINC01559

Across TCGA pan-cancer cohorts, LINC01559 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01559 data layer compared with 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01559 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01559 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

LUAD, KIRP, and BRCA are the cancer types where LINC01559 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.588	0.740	<.001	147	view →
KIRP	DFS	Quartile	All	0.299	0.850	<.001	84	view →
BRCA	OS	Quartile	All	0.875	0.943	<.001	66	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	66	view →
UVM	OS	Tertile	All	0.414	1.000	.003	53	view →
PAAD	DFS	Quartile	All	0.169	0.486	<.001	39	view →
LIHC	OS	Median	All	0.403	0.718	<.001	37	view →
UCEC	DFS	Median	All	0.569	0.725	.001	36	view →
CESC	OS	Quartile	All	0.933	0.841	.016	22	view →
ESCA	OS	Median	All	0.418	1.000	.005	21	view →
KIRC	DFS	Tertile	All	0.546	0.739	.016	20	view →
OV	DFS	Median	IV	0.329	0.567	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01559–LUAD (DFS)

Open the LUAD breakdown →